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Electrostatic binding of polyanions using self-
assembled multivalent (SAMul) ligand displays –
structure–activity eﬀects on DNA/heparin binding†
Loryn E. Fechner,a Buthaina Albanyan,a Vaˆnia M. P. Vieira,a Erik Laurini,b
Paola Posocco,b Sabrina Pricl*b and David K. Smith*a
This paper reports that modifying the ligands in self-assembled multivalent (SAMul) displays has an impact
on apparent binding selectivity towards two nanoscale biological polyanions – heparin and DNA. For the
nanostructures assayed here, spermidine ligands are optimal for heparin binding but spermine ligands
are preferred for DNA. Probing subtle diﬀerences in such nanoscale binding interfaces is a signiﬁcant
challenge, and as such, several experimental binding assays – competition assays and isothermal
calorimetry – are employed to conﬁrm diﬀerences in aﬃnity and provide thermodynamic insights. Given
the dynamic nature and hierarchical binding processes involved in SAMul systems, we employed
multiscale modelling to propose reasons for the origins of polyanion selectivity diﬀerences. The
modelling results, when expressed in thermodynamic terms and compared with the experimental data,
suggest that DNA is a shape-persistent polyanion, and selectivity originates only from ligand preferences,
whereas heparin is more ﬂexible and adaptive, and as such, actively reinforces ligand preferences. As
such, this study suggests that inherent diﬀerences between polyanions may underpin subtle binding
selectivity diﬀerences, and that even simple electrostatic interfaces such as these can have a degree of
tunability, which has implications for biological control and regulation on the nanoscale.
Introduction
Biology is dominated by polyanions, such as nucleic acids,
glycosaminoglycans, proteoglycans, micro-tubules and
membranes – subtle discrimination between these nanoscale
species is important to regulate and control this ‘polyanion
world’.1 However, discrimination between polyanions is a highly
challenging target given their similarities in terms of charge
density, their charge providing the primarymechanism by which
they can be bound. As such, in terms of supramolecular and
nanoscale chemistry, polyanions are interesting, but diﬃcult
targets for selective binding. As a result, most studies focus on
a specic anion with a dened application in mind, e.g., DNA
binding for gene delivery,2 or heparin binding for coagulation
control.3 The development of active agents in these two areas is
of considerable clinical relevance and has made these poly-
anions of great interest. Considering these two specic anions,
DNA is a negatively charged as a result of phosphate links in the
sugar backbone, while the polysaccharide backbone of heparin
is appended with anionic sulfates and carboxylates. Clearly there
are some inherent diﬀerences between these polyanions, but
surprisingly, there has been relatively little interest in probing
binding selectivity. Obviously, if we could understand the factors
which allow receptors to preferentially bind to one polyanion
over another, as well as addressing a genuine challenge in
supramolecular design, we would also be able to develop
systems that are able to intervene much more precisely in
processes of biomedical relevance and are better optimised for
specic clinical applications.2,3
Nanoscale targets such as polyanions are also a signicant
challenge for supramolecular chemistry because of their rela-
tively large, solvent-exposed surfaces.4 Eﬀective binding is best
achieved using multivalency, i.e., employing ligands with many
points of interaction.5 Given the relative diﬃculty of using
synthetic chemistry to construct covalent multivalent arrays,
there has recently been increasing interest in developing self-
assembled multivalent (SAMul) ligand displays, in which
multiple ligands non-covalently assemble to generate a nano-
scale display which interacts with a binding partner.6 This
hierarchical approach to nanoscale recognition has been used
to target (e.g.) sugar binding proteins,7 integrins,8 nucleic acids9
and heparin.10 SAMul is a tunable strategy because it only
requires the synthesis of small molecules – it is therefore easy to
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introduce structural variation and explore structure–activity
relationships. To bind polyanions such as DNA or heparin
requires cationic ligands,9,10 which bind via multiple electro-
static ion–ion interactions. We recently reported that ligand
chirality could inuence apparent heparin/DNA binding selec-
tivity,11 but selective polyanion binding, for the reasons outlined
above, remains a rarely explored, challenging target.
There has been considerable interest in colloid science in
investigating the interaction of self-assembled simple cationic
lipids with specic polyanions in both practical and theoretical
terms.12 In the widely accepted model, charge density plays the
dominant role in binding – it is noted that other interactions
can then inuence selectivity, but there are relatively few
specic experimental examples of this.13 Synthetic polyanions
have been studied, and it has been shown, for example, that
hydrophobic interactions between the polymer chain and the
hydrophobic unit in the lipid can play an important role in
moderating charge–charge binding eﬀects.14 In this paper, we
determine the impact of ligand choice in our SAMul displays
and report an experimental example in which we uncover
apparent selectivities of naturally occurring biopolyanions, DNA
and heparin, for diﬀerent nanoscale assemblies – we use mul-
tiscale modelling methods to provide further insight into the
complex, interdependent, hierarchical self-assembly and
nanoscale binding processes.
Results and discussion
For the purposes of this structure–activity eﬀect study, amphi-
philic molecules with diﬀerent ligands were synthesised (Fig. 1)
each of which could, in principle, self-assemble into micelles
displaying cationic ligand surfaces. As hydrophobe we selected
palmitic acid (C16), with diﬀerent amines as ligands, connected
using TBTU-mediated peptide coupling with an appropriate
protecting group strategy (see ESI†). This yielded C16-DAP,
C16-DAPMA, C16-SPD and C16-SPM, with nominal ligand charges
of +1, +2, +2 and +3 respectively at physiological pH (7.4). Singly-
charged C16-DAP was largely insoluble in water/buﬀer – its +1
charge is insuﬃcient to counterbalance the hydrophobicity, and
it was not studied further. Compound C16-DAPMA (+2) had
good aqueous solubility, spermidine-based C16-SPD (+2) was
slightly less soluble, and spermine-derived C16-SPM (+3) was
more diﬃcult to dissolve. We reason the +3 charge of C16-SPM
hinders assembly, and hence solubility, because cation–cation
repulsions on the micellar surface are not fully oﬀset by the
hydrophobic driving force for assembly.15
We initially quantied self-assembly using a Nile Red assay16
in 150mMNaCl. All studies in this paper were performed at this
salt concentration; ionic strength can have a major impact on
electrostatic binding and it is important to keep it constant. The
resulting critical micelle concentrations (CMCs) supported the
macroscopic solubility observations, with C16-DAPMA having
the lowest CMC and C16-SPM the highest, with C16-SPM
requiring heating to encourage solubility – in agreement with
entropically-driven hydrophobic self-assembly. Further analysis
of CMC data in diﬀerent buﬀer/salt conditions is provided in
the ESI.† For validation, we also used isothermal titration
calorimetry (ITC) and the resulting CMCs were in very good
agreement with those from the Nile Red assay (Table 1).
Importantly, treatment of the ITC data also provided thermo-
dynamic parameters for self-assembly (DHmic, TDSmic and
DGmic) which support the proposal that C16-SPM had the least
favourable self-assembly, primarily as a result of the enthalpic
term. Dynamic light scattering (DLS, Fig. S1–S3,† Table 1)
indicated, based on the volume contribution, that all three
compounds formed similar-sized assemblies, as may be ex-
pected given the relatively similar molecular sizes of the three
compounds. Perhaps surprisingly, the most highly-charged C16-
SPM actually formed the assembly with the lowest zeta potential
– signicantly lower than that observed for C16-DAPMA, which
may reect the diﬃculty of bringing these more highly charged
ligands into close proximity on the nanoscale surface. We also
used transmission electron microscopy (TEM) to visualise the
self-assembled nanostructures formed by these ligands (Fig. S4–
S6†). On drying aqueous samples on a TEM grid, we observed
that in each case, self-assembled spherical nanostructures
could be visualised, in good general agreement with the DLS
data.
To further understand self-assembly, we used multiscale
molecular simulation in 150 mM aqueous NaCl (see ESI†).17
Spherical micelles were obtained in all cases (e.g., Fig. 2).
Interestingly, simulation indicated that the compounds formed
micelles with diﬀerent packing densities. Specically, the
aggregation number (Nagg, Table 2) suggests that C16-DAPMA
Fig. 1 Compounds investigated in this paper.
Table 1 Critical Micelle Concentrations (CMCs) for compounds in 10
mM Tris buﬀer (with 150 mM NaCl) determined by Nile Red (CMCNR)
and ITC-derived thermodynamic data of micellisation (CMCITC) and
zeta sizing data (fromDLS based on the volume contribution). DGmic¼
DHmic  TDSmic, where DGmic, DHmic, and TDSmic are the free energy,
enthalpy and entropy of micellisation, respectively
C16-DAPMA (+2) C16-SPD (+2) C16-SPM
a (+3)
CMCNR/mM 40  1 51  2 65  20
CMCITC/mM 34 52 71
DHmic/kJ mol
1
10.81 8.61 8.41
TDSmic/kJ mol
1 14.72 15.86 15.29
DGmic/kJ mol
1
25.52 24.47 23.70
Diameter/nm 6.2  1.3 6.6  0.2 6.2  0.1
Zeta potential/mV +51.9  2.6 +44.0  1.7 +40.5  0.9
a Heating was required to encourage solubility under these conditions.
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forms more tightly packed micelles than C16-SPD, which in turn
is more densely packed than C16-SPM. As suggested from
experiment, the hydrophobic C16 chain struggles to bring
together the more highly charged SPM ligands. As a result of the
decrease in Nagg for C16-SPM, the electrostatic potential js also
decreases, leading to simulated zeta potentials (z, Table 2) in
good agreement with the experimental data (Table 1), with
C16-DAPMA > C16-SPD > C16-SPM.
The ability of SAMul nanostructures to bind polyanions was
then tested experimentally. DNA binding was assessed using an
ethidium bromide (EthBr) displacement assay18 in which the
compounds displace EthBr from calf thymus DNA, as moni-
tored by uorimetry. Heparin binding was monitored by UV-Vis
spectroscopy using our recently introduced Mallard Blue (MalB)
dye in a competition assay.19 All assays were performed in
triplicate. These simple, rapid approaches allowed us to deter-
mine CE50 values (cation : anion charge excess at which 50% of
dye is displaced). These can be converted into EC50 values
(eﬀective concentration of binder at the same point). Under
assay conditions, all compounds had good solubility – interac-
tions between cationic ligands and the polyanionic binding
partner decrease cation–cation repulsion at the micellar surface
(see below for further discussion).
From these rapid assays, it was found (Table 3) that the more
highly charged C16-SPM ligand appears to be the optimal DNA
binder with low CE50 and EC50 values, whereas C16-SPD and
C16-DAPMA are less eﬀective. Interestingly, although C16-DAPMA
and C16-SPD have the same ligand charge (+2), C16-DAPMA is
a slightly better DNA binder. In contrast, for heparin binding,
C16-SPD is the most charge-eﬃcient binder as measured by its
CE50 value, signicantly outperforming C16-DAPMA, even
though the latter compound was the slightly better DNA binder
and both systems have the same nominal charge. C16-SPD even
performs better than more highly charged C16-SPM in terms of
its CE50 value. Although these diﬀerences are relatively small,
they were reproducible and outside of error range – as such, they
provide some hint that heparin and DNA behave diﬀerently when
faced with these SAMul nanostructures as binding partners.
All of the reported EC50 values (Table 3) were below the CMC
values of these compounds (Table 1). Polyanions can assist self-
assembly by limiting electrostatic repulsion on the cationic
SAMul surface.20 This agrees with the observation that all
compounds showed excellent solubility in polyanion-binding
assays, unlike in their absence. It should also be noted that the
lineshapes for these binding assays are sigmoidal (Fig. 3) and
can be divided into three regions: (i) non-assembled binder
initially struggles to displace polyanion-binding dye, (ii) at
a critical concentration, binding occurs and dye displacement is
activated (iii) the system saturates and no further dye is dis-
placed. The onset of region (ii) allows us to estimate apparent
critical aggregation concentration (CAC) values in the presence
of the polyanions – see ESI† for full data. These observations are
consistent with a system that only self-assembles and binds
polyanions at a critical concentration. It is also clear that while
self-assembly evidently assists multivalent binding, the
converse is also true, and multivalent binding can considerably
assist self-assembly – reecting the dynamic nature of these
SAMul nanostructures.
We were somewhat surprised by the DNA/heparin selectivity
diﬀerences reported above, as we had anticipated that the pol-
yanions would bind to the most highly charged systems best,
Fig. 2 Mesoscopic (left) and atomistic (right) simulations of C16-SPM
self-assembling into micelles. The C16 hydrophobic portion is shown
as steel blue spheres whereas the SPM residues are portrayed as navy
blue spheres. In the left panel, water, ions and counterions are shown
as light grey ﬁeld; in the right panel, water molecules are depicted as
transparent light blue spheres, some Na+ and Cl ions are shown as
purple and green spheres, respectively.
Table 2 Main characteristics of the spherical SAMul micelles as ob-
tained from multiscale molecular simulations. Nagg ¼ aggregation
number; Dm ¼ diameter; js ¼ surface electrostatic potential; and z ¼
zeta potential
Compound Nagg Dm (nm) js (mV) z (mV)
C16-DAPMA 16  2 6.0  0.3 172.4 50.2
C16-SPD 13  1 6.3  0.1 153.3 45.1
C16-SPM 10  1 5.8  0.2 144.6 41.8
Table 3 DNA and heparin binding parameters: CE50 (cation : anion
charge excess at which 50% of indicator dye is displaced from its
complex) and EC50 (eﬀective concentration at which 50% of dye is
displaced)
C16-DAPMA (+2) C16-SPD (+2) C16-SPM (+3)
CE50 DNA 5.0  0.1 6.0  0.3 4.3  0.1
Heparin 0.69  0.05 0.34  0.05 0.49  0.01
EC50/mM DNA 10.1  0.1 11.9  0.5 5.7  0.1
Heparin 37  3 19  3 17.5  0.3
Fig. 3 Titration curves for EthBr (left, DNA binding) and MalB (right,
heparin binding) displacement. For DNA binding: [DNA] ¼ 4 mM (per
base), [EthBr]¼ 5.07 mM, buﬀer: 2 mMHEPES, 0.05 mM EDTA, 150 mM
NaCl. For heparin binding: [heparin] ¼ 27 mM (per disaccharide unit),
[MalB]¼ 25 mM, buﬀer: Tris HCl 10mM, 150mMNaCl. Blue¼C16-SPM,
red ¼ C16-SPD, green ¼ C16-DAPMA.
This journal is © The Royal Society of Chemistry 2016 Chem. Sci., 2016, 7, 4653–4659 | 4655
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and that both polyanions would exhibit similar orders of pref-
erence. As such, we therefore used ITC to further validate the
data. These experiments are complex, as there are many near-
simultaneous processes which are diﬃcult to deconvolute: (i)
non-assembled ligand binding to polyanion, (ii) ligand self-
assembly, (iii) self-assembled ligands binding to polyanion, and
(iv) further nanoscale assembly. Nonetheless, we reasoned that
we could obtain useful thermodynamic data for the overall
binding process which would still be informative (Table 4) and
would provide insight into the impact of the presence of the
polyanion on the self-assembly of the ligands. In particular, we
reasoned that comparing the data with that obtained for the
self-assembly of the ligands in the absence of polyanion (Table
1) should allow us to isolate the thermodynamic contributions
which are a direct result of ligand–polyanion interactions.
The method was based on titrating the ligand into the pol-
yanion, and therefore allowed us to determine polyanion-
modied critical aggregation concentrations (CACs). Interest-
ingly, these modied CAC values had good agreement with
those determined from the dye displacement assay (see ESI†),
which would suggest good comparability between our diﬀerent
binding assay approaches. Furthermore, ITC allowed us to
elucidate the thermodynamic parameters for SAMul self-
assembly in the presence of polyanion. By comparing these
thermodynamics of aggregation in the presence (DHagg, TDSagg
and DGagg, Table 4) and absence (DHmic, TDSmic and DGmic,
Table 1) of polyanion, we estimate the diﬀerence to represent
the eﬀective binding between the SAMul nanostructures and
the polyanion (e.g. DHbind ¼ DHagg  DHmic) (Table 4).
This simple approach allows us to extract and quantify the
eﬀective change in solution thermodynamics induced by the
polyanion.
Pleasingly, the ITC data in terms of apparent binding aﬃnity
(DGbind, bold, Table 4) were in broad agreement with the trends
obtained from the dye displacement assays. Once again, C16-SPM
was the most eﬀective DNA binder (DGbind), and C16-SPD was the
most eﬀective heparin binder, especially if the DGbind values are
normalised per charge (C16-SPD, 2.45 kJ mol
1; C16-SPM,
1.63 kJ mol1). Furthermore, as in the dye displacement assays,
for DNA binding C16-DAPMA > C16-SPD, whereas for heparin
binding C16-SPD > C16-DAPMA. Although the thermodynamic
diﬀerences are relatively small, they are in agreement with the
results of the dye displacement assay, supporting the view that
specic binding preferences are able to inuence the simple
ion–ion interactions (which provide the bulk of the binding
aﬃnity) in order to generate diﬀerent selectivity from diﬀerent
polyanions. As such, the ITC data support the view that ligand
choice directs polyanion selectivity in this system.
Considering the data in more detail, it is evident that much
of the diﬀerence in binding appears to be caused by the ability
of these polyanions to inuence the aggregation of the SAMul
ligand displays (DGagg, italics, Table 4). In the presence of DNA,
the magnitude of DGagg for C16-SPM is greater than for the other
two ligands, whereas in the presence of heparin, it is C16-SPD
which has the largest DGagg value – this is also reected in the
apparent CACs in the presence of each of these polyanions. As
such, we reason the specics of the ligand–polyanion interac-
tion can directly inuence the ability of the nanostructures to
assemble and hence, as a result, exhibit high-aﬃnity SAMul
binding.
In order to provide greater insight into the binding interface
between the self-assembled nanostructure and the polyanions
we once again turned to multiscale simulations. We brought
together the SAMul nanostructures as optimised in the absence
of polyanion with the polyanions themselves in order to probe
the binding interface. Clearly this assumes that the nano-
structures do not signicantly change in the presence of the
polyanion, which is a limitation on the method, but it provides
the only tractable approach for simulating the interactions
between these SAMul displays and polyanions in order to
provide some insight into the thermodynamics of the nanoscale
binding interface.
We note that in reality, multiple DNA helices or heparin
chains will contact a single micelle. Indeed, this is supported by
DLS data (Table S3†) recorded on the complexes formed
between these cationic micelles and either heparin or DNA.
These DLS data clearly indicate the formation of larger ill-
dened aggregates (ca. 100–300 nm in diameter) on binding.
The DLS data also provided further support for the binding
preferences reported above, with zeta potentials suggesting that
C16-SPM was most eﬀective at neutralising the negative charge
of DNA, while heparin binding reduced the cationic charge of
C16-SPD more than either of the other ligands.
It is important to consider whether the cationic micelles
actually remain intact during the polyanion binding process, as
there is a possibility that signicant reorganisation could occur.
To probe this experimentally, we employed transmission elec-
tron microscopy (TEM) to visualise the morphologies formed
when the self-assembled nanostructures bind to polyanionic
Table 4 Thermodynamic parameters of aggregation (DGagg, TDSagg
and DGagg) and critical aggregation concentrations (CACs) in the
presence of polyanion as obtained from ITCmeasurements at 298 K in
a 30 mM solution of DNA or heparin at 150 mM NaCl. Binding
parameters DHbind, TDSbind, and DGbind are deﬁned as the diﬀerence
between parameters for aggregation in the presence and absence of
polyanion, respectively (e.g., DHbind ¼ DHagg  DHmic)
C16-DAPMA
(+2)
C16-SPD
(+2)
C16-SPM
(+3)
CAC (with polyanion)/mM DNA 6.1 9.8 3.4
Heparin 13.6 7.2 9.8
DHagg/kJ mol
1 DNA 12.2 12.5 15.0
Heparin 12.8 13.5 11.0
TDSagg/kJ mol
1 DNA 17.6 16.2 16.0
Heparin 15.0 15.9 17.6
DGagg/kJ mol
1 DNA 29.8 28.7 31.0
Heparin 27.8 29.4 28.6
DHbind/kJ mol
1 DNA 1.4 3.9 6.6
Heparin 1.9 4.9 2.6
TDSbind/kJ mol
1 DNA 2.9 0.4 0.7
Heparin 0.3 0.0 2.3
DGbind/kJ mol
1 DNA 4.3 4.2 7.3
Heparin 2.2 4.9 4.9
4656 | Chem. Sci., 2016, 7, 4653–4659 This journal is © The Royal Society of Chemistry 2016
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heparin (Fig. 4). In agreement with similar literature studies on
related systems10b,11 the micelles remained remarkably intact,
and were organised into hierarchical nanoscale arrays. We
suggest this is a result of close packing interactions between the
spherical micellar polycations and the linear polyanions. As
such, we are condent that the micelles do indeed remain intact
on binding, and this supports our suggested methodological
approach for computational modelling in which the pre-formed
micelle is brought into contact with a polyanion chain in order
to determine the fundamental binding interactions.
We therefore reason, with this experimental support from
TEM, that our modelling approach which contacts a single
micelle with a single polyanion is a valid methodology for
gaining insight into the fundamental forces responsible for the
primary binding event. In this way, we were interested to
determine whether the thermodynamic insights obtained
would show broad agreement with our experimental observa-
tions of binding. Obviously, understanding the further hierar-
chical assembly event is more complex, and was beyond the
scope of this study, which was instead focussed on the diﬀer-
ences induced by diﬀerent ligands at the initial polyanion
binding interface.
For DNA binding (Fig. 5, top), the C16-SPM micelles contain
10 SPM residues, 9 of which eﬀectively contact DNA (a param-
eter we dene as Neﬀ), resulting in a charge-normalized binding
free energy (per-eﬀective-residue) DG* of 14.32 kJ mol1.
Conversely, C16-SPD and C16-DAPMA nanostructures only use 7
and 8 (out of 13 and 16) SPM residues, respectively, to bind
DNA. For C16-SPD and C16-DAPMA, the per-eﬀective-residue
interactions were lower, with DG* values of 9.76 and 10.80
kJ mol1, respectively. The simulated DG* values therefore
follow the same trend as the experimental CE50 values and ITC
data: C16-SPM > C16-DAPMA > C16-SPD.
For heparin binding (Fig. 5, bottom), the micelles formed by
C16-SPD engage 12 out of 13 available ligands in productive
binding, resulting in charge-normalized DG* of 14.98
kJ mol1. However, C16-DAPMA and C16-SPM assemblies only
exploit 9/16 and 6/10 ligands, giving DG* values of 8.65
and 11.97 kJ mol1, respectively. The predicted DG* values
are thus in agreement with the trend of experimental data:
C16-SPD > C16-SPM > C16-DAPMA.
To understand why polyanions appear to have diﬀerent
selectivities towards SAMul nanostructures, we then deconvo-
luted these overall DG* values into enthalpic (DH*) and entropic
(TDS*) components (Fig. 6 and ESI†).
Fig. 4 TEM images of self-assembled micellar nanostructures binding
to heparin to yield a hierarchically organised self-assembled nanoscale
aggregate and supporting the view that self-assembled micelles
remain stable under polyanion binding conditions: (top) C16-DAPMA,
(middle) C16-SPD, (bottom) C16-SPM. All scale bars are 100 nm.
Fig. 5 Equilibrated atomistic molecular dynamics (MD) simulation
snapshots of SAMul micelles binding DNA (upper panel, orange) and
heparin (lower panel, ﬁrebrick). In both panels, from left to right:
C16-DAPMA (light grey (C16) and plum (DAPMA)), C16-SPD (lime green
(C16) and forest green (SPD)), and C16-SPM (steel blue (C16) and navy
blue (SPM)). Hydrogen atoms, water molecules, ions and counterions
are not shown for clarity.
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For DNA binding (Fig. 5, upper panel) considered from the
viewpoint of each eﬀective SAMul cationic charge (Fig. 6A), the
exible C16-SPM (3+) ligands can enthalpically overcompensate
the signicant entropic cost associated with their organisation
on binding DNA. In part, this is due to the greater reduction in
cation–cation repulsions at the SAMul surface of C16-SPM on
DNA binding, which in turn will assist self-assembly. The other
two less-charged ligands have less enthalpic gain and bind less
well – in full agreement with the experimental ITC data (Table
4). The slightly more rigid C16-DAPMA suﬀers less entropic
penalty than C16-SPD on binding, as it does not reorganise,
slightly favouring its DNA binding over C16-SPD. Once again this
is in agreement with ITC data (Table 4).
Applying the same analysis, but from the viewpoint of each
anionic DNA charge involved at the binding interface (Fig. 6B),DG*,
DH* and TDS* are practically independent of the choice of ligand –
i.e., from the perspective of DNA, all interactions are equally good.
The selectivity of the SAMul micelles towards DNA can thus be
ascribed only to the optimization of the ligands – as such DNA
appears to be a shape-persistent21 polyanion which will simply bind
to, and organise the SAMul display with which it is presented.
For heparin binding (Fig. 6, lower panel), considered from
the viewpoint of each eﬀective SAMul cationic charge (Fig. 5C),
the enthalpic gain when C16-SPD reorganises to optimise its
interactions is greater than for C16-DAPMA and also greater
than for C16-SPM – in broad agreement with the ITC data
(DHbind, Table 4). It appears that C16-SPM is less eﬀective at
binding the more open surface of heparin in terms of enthalpic
gain than it was for DNA. Although the entropic penalty of
binding C16-DAPMA is, as for DNA binding, less than that of the
more exible C16-SPD, it is in this case outweighed by the
enthalpic term. As such, C16-SPD emerges as the optimal system
for heparin binding, in agreement with ITC (DGbind, Table 4).
Considered from the viewpoint of each heparin sugar (2),
we also observe diﬀerent behaviour depending on the ligand.
Each heparin residue oﬀsets the entropic cost of binding SPD
with a greater enthalpic gain of its own (Fig. 6D). This is in
contrast to DNA, where each anion behaved identically, irre-
spective of the ligand. As such, the more eﬀective binding of
C16-SPD induces more eﬀective binding from each residue of
the heparin chain via an enthalpy/entropy optimisation, medi-
ated through polyanion structural adaptation – i.e. heparin is an
adaptive21 polyanion, which not only binds to the SAMul display,
but importantly, is also able to adapt itself in response.
We believe that these insights, which correlate experimental
and simulation data for the challenging problem of polyanion
binding hint at fundamental diﬀerences through which some
discrimination between polyanions may be achieved. Interest-
ingly, even biology struggles to achieve selectivity between DNA
and heparin within its proteins – for example many (but not all)
DNA/RNA binding proteins also bind to heparin.22 Clearly
understanding the factors which can lead to even small degrees
of selectivity between these polyanions, and developing
synthetic nanosystems with this capacity, is therefore useful. In
this regard, it is worth noting that exibility has recently been
identied as a key factor in heparin binding proteins – which
would be supported by the view, expressed here, of this poly-
anion being an adaptive binding target.23
Conclusions
In summary, this paper demonstrates that ligand choice in
SAMul displays can have an inuence on apparent binding
selectivity. As such, electrostatic ion–ion binding depends on
structural detail, not only charge density – as conrmed by the
complementary experimental methods of competition binding
assays and isothermal calorimetry. Of the compounds studied
here, C16-SPM is optimal for DNA binding, while C16-SPD is
optimal for heparin binding. We note that the polyanions play
a role in assisting self-assembly and hence switching on the
multivalent binding eﬀect, and suggest that specics of ligand–
polyanion interactions help mediate subtle diﬀerences in this
overall process. Molecular simulation studies lead us to
propose that the shape-persistence (DNA), or adaptability
(heparin) of the polyanionic targets help mediate the selectivity
of interaction with diﬀerent ligands. These results provide
intriguing insight into molecular recognition processes at
nanoscale surfaces and suggest that SAMul can deliver some
selectivity in addressing the challenging problem of the ‘poly-
anion world’.
Acknowledgements
This work was supported by a PROMOS scholarship from Freie
Universita¨t Berlin to LEF, the Saudi Arabian Government
(Ministry of Education) via a PhD scholarship to BA and Marie
Curie ITN ‘SMART-NET’ interdisciplinary training network
funding to VMPV.
Fig. 6 Charge-normalized per-residue eﬀective free energy of
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micelle ligand-type complexed with heparin; (D) heparin sugars
complexed with each of the SAMul micelles.
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